Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05DBJ
|
||||
| Former ID |
DNC009410
|
||||
| Drug Name |
2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529392] | ||
| Formula |
C13H14N2O2S
|
||||
| Canonical SMILES |
CC1=CC(=O)N=C(N1)SCC2=CC=C(C=C2)OC
|
||||
| InChI |
1S/C13H14N2O2S/c1-9-7-12(16)15-13(14-9)18-8-10-3-5-11(17-2)6-4-10/h3-7H,8H2,1-2H3,(H,14,15,16)
|
||||
| InChIKey |
XMFWHLZTTUUQHL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Collagenase 3 | Target Info | Inhibitor | [529392] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
| Plasminogen activating cascade | |||||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.